vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Soho House & Co Inc. (SHCO). Click either name above to swap in a different company.
Soho House & Co Inc. is the larger business by last-quarter revenue ($370.8M vs $196.0M, roughly 1.9× Axsome Therapeutics, Inc.). Soho House & Co Inc. runs the higher net margin — -5.0% vs -14.6%, a 9.5% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 11.2%). Soho House & Co Inc. produced more free cash flow last quarter ($3.5M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 13.5%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Soho House is an international private members’ club with a focus on the media, arts and fashion industries.
AXSM vs SHCO — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $370.8M |
| Net Profit | $-28.6M | $-18.7M |
| Gross Margin | — | — |
| Operating Margin | -13.8% | -1.6% |
| Net Margin | -14.6% | -5.0% |
| Revenue YoY | 65.0% | 11.2% |
| Net Profit YoY | 61.9% | -10790.3% |
| EPS (diluted) | $-0.55 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | — | ||
| Q3 25 | $171.0M | $370.8M | ||
| Q2 25 | $150.0M | $329.8M | ||
| Q1 25 | $121.5M | $282.9M | ||
| Q4 24 | $118.8M | $305.6M | ||
| Q3 24 | $104.8M | $333.4M | ||
| Q2 24 | $87.2M | $302.9M | ||
| Q1 24 | $75.0M | $261.9M |
| Q4 25 | $-28.6M | — | ||
| Q3 25 | $-47.2M | $-18.7M | ||
| Q2 25 | $-48.0M | $24.9M | ||
| Q1 25 | $-59.4M | $8.2M | ||
| Q4 24 | $-74.9M | $-91.7M | ||
| Q3 24 | $-64.6M | $175.0K | ||
| Q2 24 | $-79.3M | $-29.9M | ||
| Q1 24 | $-68.4M | $-41.6M |
| Q4 25 | -13.8% | — | ||
| Q3 25 | -27.0% | -1.6% | ||
| Q2 25 | -24.5% | 18.1% | ||
| Q1 25 | -46.9% | 12.3% | ||
| Q4 24 | -61.1% | -23.1% | ||
| Q3 24 | -59.8% | 11.4% | ||
| Q2 24 | -89.5% | -4.3% | ||
| Q1 24 | -89.7% | -9.3% |
| Q4 25 | -14.6% | — | ||
| Q3 25 | -27.6% | -5.0% | ||
| Q2 25 | -32.0% | 7.5% | ||
| Q1 25 | -48.9% | 2.9% | ||
| Q4 24 | -63.1% | -30.0% | ||
| Q3 24 | -61.7% | 0.1% | ||
| Q2 24 | -91.0% | -9.9% | ||
| Q1 24 | -91.1% | -15.9% |
| Q4 25 | $-0.55 | — | ||
| Q3 25 | $-0.94 | $-0.10 | ||
| Q2 25 | $-0.97 | $0.13 | ||
| Q1 25 | $-1.22 | $0.04 | ||
| Q4 24 | $-1.54 | $-0.48 | ||
| Q3 24 | $-1.34 | $0.00 | ||
| Q2 24 | $-1.67 | $-0.15 | ||
| Q1 24 | $-1.44 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $142.5M |
| Total DebtLower is stronger | — | $735.8M |
| Stockholders' EquityBook value | $88.3M | $-351.6M |
| Total Assets | $689.8M | $2.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | — | ||
| Q3 25 | $325.3M | $142.5M | ||
| Q2 25 | $303.0M | $150.3M | ||
| Q1 25 | $300.9M | $150.1M | ||
| Q4 24 | $315.4M | $152.7M | ||
| Q3 24 | $327.3M | $142.8M | ||
| Q2 24 | $315.7M | $148.5M | ||
| Q1 24 | $331.4M | $139.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | $735.8M | ||
| Q2 25 | — | $729.8M | ||
| Q1 25 | — | $705.1M | ||
| Q4 24 | — | $691.5M | ||
| Q3 24 | — | $694.8M | ||
| Q2 24 | — | $682.1M | ||
| Q1 24 | — | $671.7M |
| Q4 25 | $88.3M | — | ||
| Q3 25 | $73.7M | $-351.6M | ||
| Q2 25 | $73.1M | $-348.6M | ||
| Q1 25 | $53.2M | $-340.1M | ||
| Q4 24 | $57.0M | $-335.1M | ||
| Q3 24 | $92.9M | $-279.4M | ||
| Q2 24 | $102.9M | $-231.7M | ||
| Q1 24 | $144.0M | $-193.0M |
| Q4 25 | $689.8M | — | ||
| Q3 25 | $669.3M | $2.7B | ||
| Q2 25 | $639.8M | $2.6B | ||
| Q1 25 | $596.7M | $2.5B | ||
| Q4 24 | $568.5M | $2.4B | ||
| Q3 24 | $561.5M | $2.6B | ||
| Q2 24 | $548.2M | $2.6B | ||
| Q1 24 | $545.7M | $2.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $34.9M |
| Free Cash FlowOCF − Capex | $-18.7M | $3.5M |
| FCF MarginFCF / Revenue | -9.6% | 0.9% |
| Capex IntensityCapex / Revenue | 0.0% | 8.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $1.0M | $34.9M | ||
| Q2 25 | $-32.4M | $41.0M | ||
| Q1 25 | $-43.4M | $22.8M | ||
| Q4 24 | $-26.2M | $26.9M | ||
| Q3 24 | $-18.6M | $20.6M | ||
| Q2 24 | $-30.1M | $36.0M | ||
| Q1 24 | $-53.5M | $6.2M |
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $988.0K | $3.5M | ||
| Q2 25 | $-32.4M | $12.4M | ||
| Q1 25 | $-43.7M | $7.5M | ||
| Q4 24 | $-26.2M | $18.5M | ||
| Q3 24 | $-18.7M | $10.3M | ||
| Q2 24 | $-30.2M | $10.2M | ||
| Q1 24 | $-53.6M | $-13.5M |
| Q4 25 | -9.6% | — | ||
| Q3 25 | 0.6% | 0.9% | ||
| Q2 25 | -21.6% | 3.8% | ||
| Q1 25 | -36.0% | 2.7% | ||
| Q4 24 | -22.1% | 6.1% | ||
| Q3 24 | -17.9% | 3.1% | ||
| Q2 24 | -34.6% | 3.4% | ||
| Q1 24 | -71.4% | -5.2% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 8.5% | ||
| Q2 25 | 0.0% | 8.7% | ||
| Q1 25 | 0.3% | 5.4% | ||
| Q4 24 | 0.0% | 2.7% | ||
| Q3 24 | 0.1% | 3.1% | ||
| Q2 24 | 0.1% | 8.5% | ||
| Q1 24 | 0.1% | 7.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.65× | ||
| Q1 25 | — | 2.79× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 117.70× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
SHCO
| Membership | $122.7M | 33% |
| Other | $122.0M | 33% |
| Membership Revenue | $58.5M | 16% |
| Other Revenue | $28.5M | 8% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $24.8M | 7% |
| Elimination Of Equity Accounted Revenue | $13.4M | 4% |
| Related Party | $2.0M | 1% |
| Soho House | $1.0M | 0% |
